ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $357,302 | -33.2% | 114,520 | -95.1% | 0.13% | -29.9% |
| Q2 2023 | $535,113 | -36.1% | 2,327,930 | -1.5% | 0.18% | -37.2% |
| Q1 2023 | $837,600 | +14.8% | 2,363,430 | +4.0% | 0.29% | -0.7% |
| Q4 2022 | $729,383 | -61.3% | 2,272,930 | -10.9% | 0.30% | -60.0% |
| Q3 2022 | $1,883,000 | -19.2% | 2,551,980 | -1.4% | 0.74% | -19.3% |
| Q2 2022 | $2,330,000 | -41.8% | 2,589,380 | +1.1% | 0.91% | -34.3% |
| Q1 2022 | $4,001,000 | -16.8% | 2,562,130 | +15.6% | 1.39% | -9.8% |
| Q4 2021 | $4,811,000 | -30.6% | 2,216,800 | +13.1% | 1.54% | -31.6% |
| Q3 2021 | $6,935,000 | -10.3% | 1,960,820 | +45.5% | 2.26% | -12.2% |
| Q2 2021 | $7,732,000 | +147.7% | 1,347,200 | +122.9% | 2.57% | +130.6% |
| Q1 2021 | $3,122,000 | – | 604,450 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 17,349,945 | $61,766,000 | 3.15% |
| Defender Capital, LLC. | 1,960,820 | $6,935,000 | 2.26% |
| Millrace Asset Group, Inc. | 613,885 | $2,185,000 | 1.36% |
| PURA VIDA INVESTMENTS, LLC | 12,223,953 | $43,517,000 | 1.32% |
| Penbrook Management LLC | 577,200 | $2,055,000 | 1.28% |
| ACT CAPITAL MANAGEMENT, LLC | 330,000 | $1,175,000 | 0.61% |
| AWM Investment Company, Inc. | 717,000 | $2,553,000 | 0.25% |
| Colonial River Wealth Management, LLC | 66,200 | $218,000 | 0.15% |
| CALIBER WEALTH MANAGEMENT, LLC | 66,200 | $218,000 | 0.15% |
| Fort Sheridan Advisors LLC | 110,000 | $392,000 | 0.13% |